Abstract
In recent years, there has been an increasing interest in non-hematopoietic pluripotent progenitor cells that are found in the bone marrow. Mesenchymal stem cells (MSCs) are the first non-hematopoietic progenitors to be isolated from the bone marrow and extensively characterized. In addition to their ability to support hematopoiesis, MSCs can differentiate into osteocytes, chondrocytes, tenocytes, adipocytes and smooth muscle cells. This article will review our current understanding of bone marrow stroma and MSCs and their potential therapeutic role in the setting of hematopoietic stem cell transplantation. Bone Marrow Transplantation (2001) 27, 235–239.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Friedenstein A . Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo. In: Thienfelder S, Rodt H, Kolb HJ (eds) Immunology Of Bone Marrow Transplantation Berlin: Springer-Verlag 1980 19–20
Haynesworth SE GJ, Goldberg VM, Caplan AI . Characterization of cells with osteogenic potential from human marrow Bone 1992 13: 81–88
Bianco P, Constantini M, Dearden L, Bonucci E . Alkaline phosphatase positive precursors of adipocytes in the human bone marrow Br J Haematol 1988 68: 401–411
Pittinger M, Mackay A, Beck S et al. Multilineage potential of adult human mesenchymal stem cells Science 1999 284: 143–147
Yoo JU, Barthel TS, Nishimura K et al. The chondrogenic potential of human bone marrow-derived mesenchymal progenitor cells J Bone Joint Surg 1998 80: 1745–1757
Prockop DJ . Marrow stromal cells as stem cells for nonhematopoietic tissues Science 1997 276: 71–74
Toksoz D, Zsebo K, Smith K et al. Support of human hematopoiesis in long term bone marrow cultures by murine stromal cells selectively expressing the membrane bound and secreted forms of the human homologue of the steel gene product, stem cell factor Proc Natl Acad Sci USA 1992 89: 7350–7354
Deans RJ, Moseley AB . Mesenchymal stem cells: biology and potential clinical uses Exp Hematol 2000 28: 875–884
Ferrari G, Cusella-DeAngelis G, Coletta M et al. Muscle regeneration by bone marrow-derived myogenic progenitors Science 1998 279: 1528–1530
Petersen B, Bowen W, Patrene K et al. Bone marrow as a potential source of hepatic oval cells Science 1999 284: 1168–1170
Eglitis MA, Mezey E . Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice Proc Natl Acad Sci USA 1997 94: 4080–4085
Azizi SA, Stokes D, Augelli BJ et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats – similarities to astrocyte grafts Proc Natl Acad Sci USA 1998 95: 3908–3913
Reyes M, Verfaillie CM . Turning marrow into brain: generation of glial and neuronal cells from adult bone marrow mesenchymal stem cells Blood 1999 94: 377a
Caplan A . Mesenchymal stem cells J Ortho Res 1991 9: 641–650
Haynesworth S, Baber M, Caplan A . Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies Bone 1992 13: 69–80
Haynesworth S, Baber M, Caplan A . Cytokine expression by human marrow derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1α J Cell Physiol 1996 166: 585–592
Majumdar MK, Thiede MA, Mosca JD et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells J Cell Physiol 1998 176: 186–192
Fried W, Kedo A, Barone J . Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma Cancer Res 1977 37: 1205–1209
McManus PM, Weiss L . Busulfan-induced chronic bone marrow failure: Changes in cortical bone, marrow stromal cells, and adherent cell colonies Blood 1984 64: 1036–1041
Uhlman DL, Verfaillie C, Jones RB, Luikart SD . BCNU treatment of marrow stromal monolayers reversibly alters haematopoiesis Br J Haematol 1991 78: 3304–3309
Simmons PJ, Przepiorka D, Thomas ED, Torok-Storb B . Host origin of marrow stromal cells following allogeneic bone marrow transplantation Nature 1987 328: 429–432
Koç O, Peters C, Raghavan S et al. Bone marrow derived mesenchymal stem cells of patients with lysosomal and peroxisomal storage diseases remain host type following allogeneic bone marrow transplantation Exp Hematol 1999 27: 1675–1681
Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta Nature Med 1999 5: 309–313
Champlin RE, Schmitz N, Horowitz MM et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT) Blood 2000 95: 3702–3709
Lazarus HM, Haynesworth SE, Gerson SL, Caplan AI . Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be rcovered from peripheral blood progenitor cell collections J Hematother 1997 6: 447–455
Pereira RF, O'Hara MD, Laptev AV et al. Marrow stromal cells as a source of progenitor cells for non-hematopoietic tissue in transgenic mice with a phenotype of osteogenesis imperfecta Proc Natl Acad Sci USA 1998 95: 1142–1147
Mosca J, Buyaner D, Kniley J et al. Biodistribution and bone marrow ‘homing’ of canine mesenchymal stem cells after culture expansion and re-infusion into a canine transplantation model Blood 1998 92: 664a
Koç O, Maitra B, Ballas C, Brewer F . Engraftment and in vivo enrichment of GFP/G156A— MGMT transduced human mesenchymal stem cells in NOD-SCID mice Mol Ther 2000 1: s85
Novelli E, Buyaner D, Chopra R et al. Human mesenchymal stem cells can enhance human CD34+ cell repopulating of NOD/SCID mice Blood 1998 92: 117a
Colter D, Class R, DiGirolamo C, Prockop D . Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow Proc Natl Acad Sci USA 2000 97: 3213–3218
Lazarus H, Haynesworth S, Gerson S et al. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use Bone Marrow Transplant 1995 16: 557–564
Koç O, Gerson S, Cooper B et al. Rapid hematopoietic recovery after co-infusion of autologous culture-expanded human mesenchymal stem cells (hMSCs) and PBPCs in breast cancer patients receiving high dose chemotherapy J Clin Oncol 2000 18: 307–316
Klyushnenkova E, Mosca J, McIntosh K . Human mesenchymal stem cells suppress allogeneic T cell responses in vitro: implications for allogeneic transplantation Blood 1998 92: 642a
McIntosh K, Klyushnenkova E, Shustova V et al. Suppression of alloreactive T cell response by human mesenchymal stem cells involves CD8+ cells Blood 1999 94: 133a
Bartholomew A, Sturgeon C, Nelson M et al. Allogeneic mesenchymal stem cells have significant immunosuppressive activity Exp Hematol 1999 27: 123a
Koç O, Peters C, Gerson S et al. Allogeneic mesenchymal stem cell transplantation in patients with genetic diseases Blood 1999 94: 132a
Allay JA, Dennis JE, Haynesworth SE et al. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors Hum Gene Ther 1997 8: 1417–1427
Ding L, Lu S, Batchu R et al. Bone marrow stromal cells as a vehicle for gene transfer Gene Therapy 1999 6: 1611–1616
Krebsbach P, Gu K, Franceschi R, Rutherford R . Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo Hum Gene Ther 2000 11: 1201–1210
Hurwitz D, Krichgesser M, Merrill W, Gellanapoulos T . Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells Hum Gene Ther 1997 8: 137–156
Chuah MK, Van Damme A, Zwinnen H et al. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice Hum Gene Ther 2000 11: 729–738
Horwitz E, Gordon P, Koo W et al. Transplanted gene-marked marrow mesenchymal stem cells engraft and benefit children with severe osteogenesis imperfecta: a pilot trial for cell and gene therapy of mesenchymal disorders Mol Ther 2000 1: s279
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koç, O., Lazarus, H. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant 27, 235–239 (2001). https://doi.org/10.1038/sj.bmt.1702791
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702791
Keywords
This article is cited by
-
Human delta like 1-expressing human mesenchymal stromal cells promote human T cell development and antigen-specific response in humanized NOD/SCID/IL-2R\(\upgamma \)null (NSG) mice
Scientific Reports (2021)
-
Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues
Stem Cell Research & Therapy (2016)
-
Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2
In Vitro Cellular & Developmental Biology - Animal (2013)
-
Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy
Annals of Hematology (2013)
-
Immunosuppressive Properties of Mesenchymal Stem Cells
Stem Cell Reviews and Reports (2012)